How We Work 

We work with your organization and the cooperative groups' therapeutic committee and headquarter leadership.  We start by checking scientific interest.  If scientific interest is present, next we look to investigate trial feasibility, high level cost, and timelines with our academic groups.  The end result is a budget for additional indication studies that meets the scientific interest of independent academic cooperative groups combined with clinical trial timelines for review at your internal corporate review committee meetings.

 

If the trial is approved, we will continue to co-create and execute a model with the cooperative groups that produces data that meets the standards required for submitting data to health authorities while seeking to achieve competitive timelines.